Joyzyme Group (HKSE:08622) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08622 Joyzyme Group Ltd HKSE:08622
40 GF Score
Price HK$0.17
GF Value HK$0.17
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Joyzyme Group FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:08622
40GF Score
Joyzyme Group Ltd HKSE:08622
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Joyzyme Group (HKSE:08622) Overvalued in 2026?

Based on GuruFocus' analysis, Joyzyme Group stock appears to be undervalued. The current stock price of HK$0.17 is trading 2.9% below its estimated GF Value™ of HK$0.17. GuruFocus considers Joyzyme Group to be Fairly Valued.

Key valuation signals for HKSE:08622:

  • FFO:
  • GF Value™: HK$0.17 vs. price of HK$0.17 (2.9% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the HKSE:08622 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Joyzyme Group Business Description

Address No.16 Yinkui Road, 1-3 floor and 5th floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Joyzyme Group Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in research and development, manufacture, marketing, and sale of biological reagents and auxiliary reproductive supplies and equipment, and healthcare products and supplements in the People's Republic of China (the PRC). It operates in two segments: Biological reagents and auxiliary reproductive supplies and equipment, and Healthcare products and supplements. It generates the majority of its revenue from the biological reagents and auxiliary reproductive supplies and equipment segment. Geographically, it generates revenue from the PRC.
40GF Score

Get the complete analysis for HKSE:08622

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.17
Price
HK$0.17
GF Value